Prevalence of Candida sp. in the cervical–vaginal cytology stained by Harris–Shorr

Colombo-Souza, Patrícia; Storti-Filho, Agenor; Souza, R. J. S.; Damke, Edílson; Mello, I. C. J.; Pereira, M. W.; Svidizinski, Terezinha Inez Estivalet; Consolaro, Márcia Edilaine Lopes

doi:10.1007/s00404-008-0765-6

Cited by 12 publications

(12 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As per the investigation of Jamilian et al [6] , C. albicans was confined in 42.03% of VVC patients, while in the rest of the cases, the sickness was caused by other Candida species. This example of progress was likewise noted in different nations [2,5,9] . Ahmad et al [9] detailed a pervasiveness of 53.1% of non-albicans species among patients with VVC, where C. glabrata (36.7%) was the most well-known secluded species.…”

Section: Introductionsupporting

confidence: 60%

“…Vulvovaginal Candidiasis (VVC), as an imperative subtype, is portrayed by extreme tingling of vulva, anomalous vaginal release, erythema, edema of vulva, and satellite injuries [1] . Numerous examinations have appeared 75% of the female populace will have somewhere around one scene of VVC and 40 -half will have intermittent episodes, amid their lifetime [2,4] . In spite of a few treatment modalities and use of new successful medications, VVC is an intricate and extensive issue in gynecology and obstetrics [4] .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Antifungals susceptibility pattern of Candida spp. isolated from female genital tract our experience at a tertiary care teaching hospital

C¹,

Sahoo²,

Panigrahi³

2019

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

Introduction: Vaginal candidiasis is considered as an essential general medical issue worldwide and its rate has expanded these days. As of late, unseemly and unbalanced utilization of antifungal medications, auto medication and in addition rebelliousness have caused tranquilize obstruction. Methods: This examination went for deciding the in vitro antifungal weakness examples of Candida species detached from female genital tract at IMS and SUM Hospital in Bhubaneswar, Odisha, India. Two hundred and fourthy five ladies (age run: 15 years to 49 years) going to the clinic were selected among January and December 2018 in this cross sectional investigation. Vaginal smears were gathered utilizing sterile swabs from every member and refined on sabouraud dextrose agar enhanced with chloramphenico l 0.5%; distinguishing proof of Candida spp. was performed following standard strategies. The plate dissemination technique was utilized for antifungal vulnerability testing. Results: Out of the 245 vaginal smears gathered, 94 (38.4%) strains of yeast were segregates among which 43 (45.7%) were Candida albicans and 51 (54.3%) were non albicans. The most elevated helplessness of the segregates was seen for nystatin 62 (83.78%), ketoconazole 61 (82.43%) and fluconazole 60 (81.08%). Conclusion: In spite of the detectable opposition of Candida spp. secludes to miconazole and itraconazole, the outcomes show that nystatin, ketoconazole and fluconazole are the medications of decision for the treatment of vaginal candidiasis in this area.

show abstract

Section: Introductionsupporting

confidence: 60%

Section: Introductionmentioning

confidence: 99%

Antifungals susceptibility pattern of Candida spp. isolated from female genital tract our experience at a tertiary care teaching hospital

C¹,

Sahoo²,

Panigrahi³

2019

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

show abstract

“…5 75% of the sexually active women have been found to have symptomatic vaginal candidiasis at least once in their life and 40-50% will have recurrent episodes during their lifetime. [6][7][8][9] In spite of several treatment modalities and application of new effective drugs, VVC is a complex and considerable problem in gynecology and obstetrics. 10 In present study, Candida species was isolated in 42 cases (22.8%), out of the total 184 women.…”

Section: Discussionmentioning

confidence: 99%

Untitled

2019

MIJMIC

View full text Add to dashboard Cite

Background: Vulvovaginal candidiasis is a commonly reported gynecological condition. It is a major cause of mental distress and economic costs in women of reproductive age group. Aim: To determine the prevalence of vulvovaginal candidiasis in symptomatic women of reproductive age group. Material and Methods: A total number of 184 women aged 15-45 years, attending obstetrics and gynecology outpatient department were included in the present study. A detailed clinical history was taken from the patients regarding age, use of contraception, associated comorbid conditions. Two high vaginal swabs were collected from posterior vaginal wall with aseptic precautions and sent to Microbiology department for further processing. Results: The prevalence of VVC in the present study was 22.8%. Amongst various age groups, 26-30yr (40%) followed by 31-35yr (22.6%) and 21-25yr (16.7%) showed higher percent of Candida positive cases. PID 12 (28.6%) was most commonly associated followed by cases having previous episode of vaginitis 4 (9.5%).OC Pill 9 (21.4%) was most commonly used contraceptive followed by Condom 8 (19.1%). Conclusion: A prevalence of 22.8% of vaginal candidiasis was found in women of reproductive age group of 15-45 years in the present study. Candida species can cause infection at any point in the reproductive life leading to genital discomfort and is a major reason for frequent hospital visits.

show abstract

“…It is commonly thought that the environment of BV is not conducive to blastospore multiplication, and that fungal infection therefore does not occur in the presence of BV [6]. Souza et al [7] noted that the most common bacterial flora associated with 3,125 instances of Candida spp. was of lactobacilli, present in 73.63% of the instances, followed by mixed flora (25.40%) and BV (0.73%).…”

Section: Discussionmentioning

confidence: 99%

“…The relationship between Candida albicans and BV remains controversial [5,6,7,8,9,10,11,12]. It is generally thought that coexisting C. albicans and BV are rare [5]; the reasoning behind this is that the growth requirements of the two are completely opposite to each other [6], but a recent study has indicated that this view is incorrect [10].…”

Section: Introductionmentioning

confidence: 99%

C<b><i>andida albicans </i></b>and Bacterial Vaginosis Can Coexist on Pap Smears

Wei

Fu²,

Liu³

et al. 2012

Acta Cytologica

View full text Add to dashboard Cite

Objective: The aim of our study was to study the relationship of blastospores and pseudohyphae in Papanicolaou (Pap) smears and Nugent scores for bacterial vaginosis (BV). Study Design: A total of 471 Pap smears with Candida albicans were reviewed. The presence of blastospores and pseudohyphae was established. The Pap smears were restained with the Gram stain method to evaluate the bacterial flora according to the Nugent scoring system. Results: Of the 471 Pap smears, blastospores and pseudohyphae were observed in 62.8% (296/471) and 37.2% (175/471) of the smears, and displayed symptoms in 4.4% (13/296) and 43.4% (76/175), respectively. A significant difference was found between these 2 groups (p < 0.0001). A positive BV Nugent score (≥ 7) was found in 22.1% (104/471) of the C. albicans cases. Blastospores and pseudohyphae with BV were 14.2% (42/296) and 35.4% (62/175), respectively. These high Nugent scores indicate statistically significant differences (p < 0.0001). Conclusion:C. albicans and BV can coexist. The presence of blastospores in these C. albicans cases was negatively related to symptoms.

show abstract

Prevalence of Candida sp. in the cervical–vaginal cytology stained by Harris–Shorr

Abstract: With the results obtained, it was noticed that the socio-economical level does not seem to influence the epidemiology of the Candida sp. and pointed to a balance in terms of numbers of this agent in Maringá, Paraná, Brazil.

Cited by 12 publications

References 11 publications

Antifungals susceptibility pattern of Candida spp. isolated from female genital tract our experience at a tertiary care teaching hospital

Antifungals susceptibility pattern of Candida spp. isolated from female genital tract our experience at a tertiary care teaching hospital

Untitled

C<b><i>andida albicans </i></b>and Bacterial Vaginosis Can Coexist on Pap Smears

Contact Info

Product

Resources

About